NIH-funded research Fellowship grant

Understanding how gut bacteria changes may influence lung cancer development.

Official title: Dissecting the role of gut microbiome dysbiosis in lung cancer development and progression.

Funded at University of Tx Md Anderson Can Ctr · NIH-11066881 · Data updated 2026-11-12

This study is looking at how changes in gut bacteria might be linked to lung cancer, especially in people who have smoked, and it hopes to find new ways to help prevent and treat this type of cancer.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 1, 2025
Project endMay 31, 2028
Funding year2025
Award (this year)$37,598
NIH project number1F31CA298051-01
Project IDNIH-11066881 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of tobacco use who are at high risk for developing lung adenocarcinoma.

Less likely to help

Patients who do not have a history of tobacco use or those with other types of lung cancer may not benefit from this research.

What this research studies

This research investigates the connection between gut microbiome changes and the development of lung adenocarcinoma, the most common type of lung cancer. It focuses on how alterations in gut bacteria can lead to systemic inflammation that may promote tumor growth, particularly in individuals with a history of tobacco use. By studying mouse models that mimic human conditions, the research aims to uncover the mechanisms by which gut microbiome dysbiosis affects lung cancer progression. The findings could lead to new strategies for prevention and treatment in high-risk populations.

Why it matters

Potential benefit: If successful, this research could provide insights into new preventive measures or treatments for lung cancer, particularly for individuals at high risk.

How similar studies have gone: Previous studies have shown promising results in understanding the role of gut microbiome in cancer development, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Liu, Yuejiang — University of Tx Md Anderson Can Ctr
  • Study coordinator: Liu, Yuejiang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.